TY - JOUR
T1 - Comparing Machine Learning Techniques for Blood Glucose Forecasting Using Free-living and Patient Generated Data
AU - Hameed, Hadia
AU - Kleinberg, Samantha
N1 - Publisher Copyright:
© 2020 H. Hameed & S. Kleinberg.
PY - 2020
Y1 - 2020
N2 - Managing a chronic disease like Type 1 diabetes (T1D) is both challenging and time consuming, but new technologies that allow continuous measurement of glucose and delivery of insulin have led to significant improvements. The development of an artificial pancreas (AP), which algorithmically determines insulin dosing and delivers insulin in a fully automated way, may transform T1D care but it is not yet widely available. Patient-led alternatives, like the Open Artificial Pancreas (OpenAPS), are being used by hundreds of individuals and have also led to a dramatic increase in the availability of patient generated health data (PGHD). All APs require an accurate forecast of blood glucose (BG). While there have been efforts to develop better forecasts and apply new ML techniques like deep learning to this problem, methods are often tested on small controlled datasets that do not indicate how they may perform in reality - and the most advanced methods have not always outperformed the simplest. We introduce a rigorous comparison of BG forecasting using both a small controlled research dataset and large heterogeneous PGHD. Our comparison advances the state of the art in BG forecasting by providing insight into how methods may fare when moving beyond small controlled studies to real-world use.
AB - Managing a chronic disease like Type 1 diabetes (T1D) is both challenging and time consuming, but new technologies that allow continuous measurement of glucose and delivery of insulin have led to significant improvements. The development of an artificial pancreas (AP), which algorithmically determines insulin dosing and delivers insulin in a fully automated way, may transform T1D care but it is not yet widely available. Patient-led alternatives, like the Open Artificial Pancreas (OpenAPS), are being used by hundreds of individuals and have also led to a dramatic increase in the availability of patient generated health data (PGHD). All APs require an accurate forecast of blood glucose (BG). While there have been efforts to develop better forecasts and apply new ML techniques like deep learning to this problem, methods are often tested on small controlled datasets that do not indicate how they may perform in reality - and the most advanced methods have not always outperformed the simplest. We introduce a rigorous comparison of BG forecasting using both a small controlled research dataset and large heterogeneous PGHD. Our comparison advances the state of the art in BG forecasting by providing insight into how methods may fare when moving beyond small controlled studies to real-world use.
UR - http://www.scopus.com/inward/record.url?scp=85131265202&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131265202&partnerID=8YFLogxK
M3 - Conference article
AN - SCOPUS:85131265202
VL - 126
SP - 871
EP - 894
JO - Proceedings of Machine Learning Research
JF - Proceedings of Machine Learning Research
T2 - 5th Machine Learning for Healthcare Conference, MLHC 2020
Y2 - 7 August 2020 through 8 August 2020
ER -